General Hospital of Shenyang military area command of Chinese PLA
Welcome,         Profile    Billing    Logout  
 11 Trials 
2 Trials

   Remove FilterRemove Filter

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Chen, HuiSheng
CRAD-001-03, NCT05295173: A Study of r-PA Treating Patients With Acute Ischemic Stroke(RAISE)

Completed
3
1412
RoW
Injection of recombinant human tissue plasminogen kinase derivatives, Reteplase, brand name: Ruitongli, r-PA, Recombinant human tissue plasminogen activator, Alteplase, brand name: Actilyse, rt-PA
Angde Biotech Pharmaceutical Co., Ltd., Beijing Tiantan Hospital
Acute Ischemic Stroke
06/23
06/23
BHV3000-318, NCT05371652: A Study to Learn About the Long-term Safety of Rimegepant for the Acute Treatment of Migraine in Chinese Participants

Completed
3
241
RoW
Rimegepant 75mg Orally Disintegrating Tablets (ODT)
Pfizer, Bioshin (Shanghai) Consulting Services Co., Ltd
Acute Migraine
02/24
02/24

Download Options